Trial
NCT05826015
AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
National Cancer Institute (NCI); Aravive, Inc.
Condition
Recurrent High Grade Uterine Cancer
Intervention
Paclitaxel
Why stopped
Trial did not go forward
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-02